RecruitingNot ApplicableNCT07442669

Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration

Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration: A Pilot Study


Sponsor

Hackensack Meridian Health

Enrollment

100 participants

Start Date

Aug 18, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This prospective randomized controlled study aims to determine if using a lung ultrasound score can lead to a faster diagnosis of severe respiratory distress syndrome and quicker administration of surfactant in moderately and late-preterm infants. The research will involve 100 infants, with 67 in the prospective group and 33 serving as controls. The primary goal is to shorten the time to treatment for these vulnerable newborns. The study will also assess whether this ultrasound-guided approach improves short-term respiratory outcomes. These secondary objectives include measuring any decrease in the need for and duration of mechanical ventilation, the length of non-invasive respiratory support, and the overall need for oxygen. The study population includes infants born between 27 and 34 6/7 weeks of gestation who are admitted to the NICU. Each participant will be monitored from birth until they are discharged or transferred. This research aligns with a growing body of evidence suggesting that lung ultrasound can be a valuable tool in neonatal care, potentially leading to earlier and more precise treatment for respiratory distress syndrome.


Eligibility

Min Age: 27 WeeksMax Age: 34 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Lung ultrasound for people with respiratory distress syndrome in premature infant and respiratory distress syndrome, newborn. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTLung ultrasound

Lung ultrasounds informing the decision-making on the Surfactant Administration


Locations(1)

Hackensack Univeristy Medical Center

Hackensack, New Jersey, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07442669


Related Trials